Abstract:Prostaglandin E2 (PGE2) is involved in numerous physiological and pathological processes of the kidney via its four receptors. A previous study has suggested that a defect in the PGE2 receptor 1 (EP1) gene markedly suppressed the transforming growth factor‑β1 (TGF‑β1)‑induced mesangial cell (MC) proliferation and extracellular matrix aggregation. Therefore, the present study aimed to adopt a pharmacological method of specifically suppressing or activating the EP1 receptor to further verify and demonstrate these results. The EP1 receptor antagonist SC‑19220 and EP1 receptor agonist 17‑phenyl‑trinor‑PGE2 ethyl amide (17‑pt‑PGE2) were selectively used to treat five‑sixths nephrectomy renal fibrosis model mice and TGF‑β1‑stimulated MCs. An Alpha screen PGE2 assay kit, flow cytometry, western blotting and immunohistochemical techniques were adopted to perform in vivo and in vitro experiments. The present results suggested that compared with the control group, the selective EP1 receptor antagonist SC‑19220 improved renal function, markedly reduced the plasma blood urea nitrogen and creatinine levels (P<0.05) and alleviated glomerulosclerosis (P<0.05). By contrast, the EP1 receptor agonist 17‑pt‑PGE2 aggravated renal dysfunction and glomerulosclerosis (P<0.05). To verify the renal protection mechanisms mediated by suppression of the EP1 receptor, the expression levels of endoplasmic reticulum stress (ERS)‑related proteins, including chaperone glucose‑regulated protein 78 (GRP78), transient receptor potential channel 1 (TRPC1) and protein kinase R‑like endoplasmic reticulum kinase (PERK), were further evaluated histologically. The expression of GRP78, TRPC1 and PERK in the antagonist treatment group were markedly downregulated (P<0.05), whereas those in the agonist treatment group were upregulated (P<0.05). The present in vitro experiments demonstrated that, compared with the control group, the EP1 receptor antagonist suppressed the expression of GRP78, TRPC1 and PERK (P<0.05), reduced the production of PGE2 (P<0.05) and decreased the MC apoptosis rate (P<0.05), thus alleviating TGF‑β1‑stimulated MC injury. Consequently, consistent with previous results, selectively antagonizing the EP1 receptor improved renal function and mitigated glomerulosclerosis, and its potential mechanism might be associated with the suppression of ERS.

Uric acid up-regulates the expression of prostanoid 2 in the glomerular mesangial cells through the p38MAPK pathway

Uric Acid Stimulates Rat Glomerular Mesangial Cells Proliferation Via Activation of Extracellular Signal-Regulated Kinases

Cox-2/Mpges-1/Pge(2) Cascade Activation Mediates Uric Acid-Induced Mesangial Cell Proliferation

Activation of ERK1/2 by NADPH Oxidase-Originated Reactive Oxygen Species Mediates Uric Acid-Induced Mesangial Cell Proliferation.

Uric acid stimulates proliferative pathways in vascular smooth muscle cells through the activation of p38 MAPK, p44/42 MAPK and PDGFRβ

Effect of Advanced Glycation End Products on Expression of Urotensin II and G-Protein-Couple Receptor mRNAs in Rat Mesangial Cells

Uric acid causes vascular smooth muscle cell proliferation by entering cells via a functional urate transporter.

Role of the Prostaglandin E2 Receptor Agonists in TGF-β1-induced Mesangial Cell Damage.

Elevated Uric Acid Levels Promote Vascular Smooth Muscle Cells (VSMC) Proliferation via an Nod-Like Receptor Protein 3 (NLRP3)-Inflammasome-Dependent Mechanism

Uric acid induced epithelial−mesenchymal transition of renal tubular cells through PI3K/p‐Akt signaling pathway

Role of the Prostaglandin E2/E-prostanoid 2 Receptor Signalling Pathway in TGFβ-induced Mice Mesangial Cell Damage.

Effect of selective inhibition or activation of PGE2 EP1 receptor on glomerulosclerosis

Endothelin-1 Stimulates Cytosolic Phospholipase A2 Activity and Gene Expression in Rat Glomerular Mesangial Cells.

Ganoderic Acid A Inhibits High Glucose-Induced Oxidative Stress and Extracellular Matrix Accumulation in Rat Glomerular Mesangial Cells

Effects of Advanced Glycation End Products on the Mrna Expression of Urotensin II and G Protein-Coupled Receptor in Rat Mesangial Cells

Abstract 165: Defining the Cox-2/pge2/ep4,1 Pathway in Mediating Ang Ii-induced (pro)renin Receptor Expression in Primary Rat Inner Medullary Collecting Duct Cells

Uric acid and angiotensin II additively promote inflammation and oxidative stress in human proximal tubule cells by activation of toll‐like receptor 4

Peroxisome proliferator-activated receptor γ prevents the production of NOD-like receptor family, pyrin domain containing 3 inflammasome and interleukin 1β in HK-2 renal tubular epithelial cells stimulated by monosodium urate crystals

Expression of USP2-69 in mesangial cells in vivo and in vitro.

High Uric Acid Induces Epithelial-Mesenchymal Transition of Renal Tubular Epithelial Cells Via TLR4/NF-κB Signaling Pathway

High uric acid induces phenotypic transition of renal tubular cells via PI3K/Akt signaling pathway